With the recent developments, positive analyst's coverage could be forthcoming. Just my opinion.
We need phase 3 items.
Has anyone kept track of when our multiple Phase 2 trials will be generating interim and final results? Just wondering what inflection points our yahoo message board community sees coming in 2013.
That too, but we need "coverage" also. We need this stock over $5.